Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for CGEM

Stock Name	Cullinan Oncology LLC
Ticker	CGEM(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US2300311063

Show aggregate CGEM holdings

News associated with CGEM

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Rating of “Buy” by Brokerages: Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have been assigned an average recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the […] - 2025-08-28 02:56:53
5 Biotech Stocks To Watch Ahead Of Major Clinical Trial Data Readouts In September 2025: (RTTNews) - September 2025 could be a make-or-break month for some biotech stocks, as the companies prepare to release critical clinical trial data. - 2025-08-27 06:40:47
Morgan Stanley Has Lowered Expectations for Cullinan Therapeutics (NASDAQ:CGEM) Stock Price: Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price target lowered by Morgan Stanley from $35.00 to $28.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price objective points to a potential upside of 269.39% from the stock’s current price. […] - 2025-08-20 02:46:46
Exchange Traded Concepts LLC Has $107,000 Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Exchange Traded Concepts LLC raised its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 42.6% during the 1st quarter, HoldingsChannel reports. The fund owned 14,107 shares of the company’s stock after purchasing an additional 4,216 shares during the period. Exchange Traded Concepts LLC’s holdings in Cullinan Therapeutics were worth $107,000 as […] - 2025-06-25 04:57:01
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Sees Significant Decline in Short Interest: Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 5,990,000 shares, a drop of 19.9% from the April 30th total of 7,480,000 shares. Currently, 16.7% of the company’s shares are short sold. Based on an […] - 2025-06-02 05:08:54
Tower Research Capital LLC TRC Grows Stock Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Tower Research Capital LLC TRC grew its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 411.3% during the 4th quarter, HoldingsChannel reports. The fund owned 8,800 shares of the company’s stock after buying an additional 7,079 shares during the period. Tower Research Capital LLC TRC’s holdings in Cullinan Therapeutics were worth […] - 2025-05-09 05:55:00
Wells Fargo & Company MN Acquires 8,056 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Wells Fargo & Company MN lifted its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 47.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,864 shares of the company’s stock after acquiring an additional 8,056 […] - 2025-05-07 04:24:54
Barclays PLC Sells 3,383 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Barclays PLC lowered its holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 245,231 shares of the company’s stock after selling 3,383 shares during the period. Barclays PLC’s holdings in Cullinan […] - 2025-04-30 05:50:47
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Stock Position Decreased by Legal & General Group Plc: Legal & General Group Plc decreased its position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 7.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 42,808 shares of the company’s stock after selling 3,649 shares during the quarter. Legal & General Group Plc’s holdings in Cullinan Therapeutics were worth $521,000 as of […] - 2025-04-30 04:52:47
Brokerages Set Cullinan Therapeutics, Inc. (NASDAQ:CGEM) PT at $34.80: Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have covered the stock in the […] - 2025-04-30 02:34:45
23,500 Shares in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Purchased by ExodusPoint Capital Management LP: ExodusPoint Capital Management LP bought a new stake in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 23,500 shares of the company’s stock, valued at approximately $286,000. Other hedge funds and other institutional investors also recently made changes […] - 2025-04-14 05:05:19
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Holdings Raised by American Century Companies Inc.: American Century Companies Inc. raised its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 11.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 100,721 shares of the company’s stock after buying an additional 10,010 shares during the period. American Century Companies Inc.’s holdings in Cullinan Therapeutics were worth […] - 2025-04-11 04:37:03
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Takes Position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM): Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 11,153 shares of the company’s stock, valued at approximately $136,000. Other large investors have […] - 2025-01-31 07:37:08
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Expected to Rise, HC Wainwright Analyst Says: Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price objective boosted by investment analysts at HC Wainwright from $28.00 to $33.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 200.55% from the stock’s […] - 2025-01-31 06:38:56

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) CGEM holdings

Date	Number of CGEM Shares Held	Base Market Value of CGEM Shares	Local Market Value of CGEM Shares	Change in CGEM Shares Held	Change in CGEM Base Value	Current Price per CGEM Share Held	Previous Price per CGEM Share Held
2025-12-03 (Wednesday)	42,584	USD 447,132	USD 447,132	0	USD 12,775	USD 10.5	USD 10.2
2025-12-02 (Tuesday)	42,584	USD 434,357	USD 434,357	1,545	USD -6,812	USD 10.2	USD 10.75
2025-12-01 (Monday)	41,039	USD 441,169	USD 441,169	0	USD -25,444	USD 10.75	USD 11.37
2025-11-28 (Friday)	41,039	USD 466,613	USD 466,613	103	USD -13,976	USD 11.37	USD 11.74
2025-11-27 (Thursday)	40,936	USD 480,589	USD 480,589	0	USD 0	USD 11.74	USD 11.74
2025-11-26 (Wednesday)	40,936	USD 480,589	USD 480,589	309	USD 1,597	USD 11.74	USD 11.79
2025-11-25 (Tuesday)	40,627	USD 478,992	USD 478,992	613	USD -38,389	USD 11.79	USD 12.93
2025-11-24 (Monday)	40,014	USD 517,381	USD 517,381	0	USD 138,448	USD 12.93	USD 9.47001
2025-11-21 (Friday)	40,014	USD 378,933	USD 378,933	0	USD 30,011	USD 9.47001	USD 8.72
2025-11-20 (Thursday)	40,014	USD 348,922	USD 348,922	-412	USD 7,322	USD 8.72	USD 8.45001
2025-11-19 (Wednesday)	40,426	USD 341,600	USD 341,600	103	USD -2,758	USD 8.45001	USD 8.53999
2025-11-18 (Tuesday)	40,323	USD 344,358	USD 344,358	612	USD -3,907	USD 8.53999	USD 8.76999
2025-11-17 (Monday)	39,711	USD 348,265	USD 348,265	206	USD 10,497	USD 8.76999	USD 8.55001

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CGEM by Blackrock for IE00BDZVHG35

Show aggregate share trades of CGEM

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 1,545 11.150 10.125 10.227 USD 15,801 9.39
2025-11-28 BUY 103 12.010 11.250 11.326 USD 1,167 9.38
2025-11-26 BUY 309 12.200 11.435 11.511 USD 3,557 9.35
2025-11-26 BUY 309 12.200 11.435 11.511 USD 3,557 9.35
2025-11-25 BUY 613 12.980 11.220 11.396 USD 6,986 9.34
2025-11-20 SELL -412 9.290 8.530 8.606 USD -3,546 9.33 Profit of 296 on sale
2025-11-19 BUY 103 8.730 8.230 8.280 USD 853 9.33
2025-11-18 BUY 612 8.950 8.420 8.473 USD 5,185 9.33
2025-11-17 BUY 206 9.080 8.360 8.432 USD 1,737 9.34
2025-11-14 BUY 103 8.835 7.930 8.020 USD 826 9.34
2025-11-12 BUY 103 8.490 7.720 7.797 USD 803 9.35
2025-11-10 BUY 102 8.000 7.380 7.442 USD 759 9.37
2025-11-06 BUY 102 7.820 7.060 7.136 USD 728 9.39
2025-11-04 BUY 103 7.800 7.360 7.404 USD 763 9.42
2025-10-30 BUY 515 8.090 7.550 7.604 USD 3,916 9.44
2025-10-29 BUY 206 7.690 8.570 8.482 USD 1,747 9.45
2025-10-22 SELL -408 8.120 8.650 8.597 USD -3,508 9.49 Profit of 365 on sale
2025-10-20 BUY 204 8.560 8.580 8.578 USD 1,750 9.50
2025-10-17 BUY 509 7.855 8.660 8.579 USD 4,367 9.51
2025-10-15 BUY 808 8.630 8.650 8.648 USD 6,988 9.52
2025-10-03 BUY 728 5.900 6.020 6.008 USD 4,374 9.55
2025-10-02 BUY 104 5.750 6.050 6.020 USD 626 9.57
2025-09-30 BUY 208 5.930 6.055 6.042 USD 1,257 9.62
2025-09-26 BUY 208 5.960 6.100 6.086 USD 1,266 9.66
2025-09-25 BUY 208 5.990 6.100 6.089 USD 1,267 9.68
2025-09-18 BUY 105 6.340 6.400 6.394 USD 671 9.70
2025-09-17 BUY 315 5.930 6.410 6.362 USD 2,004 9.73
2025-07-17 SELL -204 7.770 7.960 7.941 USD -1,620 9.79 Profit of 378 on sale
2025-07-11 SELL -824 7.700 7.830 7.817 USD -6,441 9.85 Profit of 1,673 on sale
2025-07-02 BUY 5,665 7.760 8.050 8.021 USD 45,439 9.90
2025-06-25 BUY 204 7.920 8.000 7.992 USD 1,630 9.96
2025-06-11 BUY 206 8.980 9.250 9.223 USD 1,900 10.09
2025-06-10 BUY 206 9.030 9.160 9.147 USD 1,884 10.10
2025-06-04 SELL -103 9.070 9.360 9.331 USD -961 10.13 Profit of 83 on sale
2025-04-23 BUY 103 8.380 8.790 8.749 USD 901 10.79
2025-04-10 SELL -816 7.580 7.610 7.607 USD -6,207 11.08 Profit of 2,836 on sale
2025-04-08 SELL -102 7.320 7.830 7.779 USD -793 11.16 Profit of 345 on sale
2025-04-07 SELL -102 7.250 7.390 7.376 USD -752 11.21 Profit of 391 on sale
2025-04-04 SELL -515 7.410 7.615 7.594 USD -3,911 11.25 Profit of 1,885 on sale
2025-04-01 BUY 420 7.500 7.550 7.545 USD 3,169 11.34
2025-03-31 SELL -312 7.570 7.900 7.867 USD -2,455 11.39 Profit of 1,098 on sale
2025-03-21 BUY 2,745 8.520 8.760 8.736 USD 23,980 11.63
2025-03-14 SELL -1,520 8.790 9.010 8.988 USD -13,662 11.83 Profit of 4,317 on sale
2025-03-07 SELL -190 8.710 9.090 9.052 USD -1,720 12.07 Profit of 572 on sale
2025-03-04 SELL -95 8.130 8.315 8.296 USD -788 12.24 Profit of 375 on sale
2025-02-25 BUY 190 8.560 8.830 8.803 USD 1,673 12.57
2025-02-19 SELL -94 9.430 9.470 9.466 USD -890 12.83 Profit of 316 on sale
2025-02-13 BUY 282 9.590 9.960 9.923 USD 2,798 13.10
2025-02-12 BUY 94 9.890 9.950 9.944 USD 935 13.16
2025-02-11 BUY 376 9.810 10.270 10.224 USD 3,844 13.23
2024-12-30 SELL -2,885 12.200 12.280 12.272 USD -35,405 14.39 Profit of 6,096 on sale
2024-11-18 SELL -1,500 13.450 14.145 14.076 USD -21,113 16.01 Profit of 2,905 on sale
2024-11-08 SELL -100 16.020 16.450 16.407 USD -1,641 16.01 Loss of -40 on sale
2024-10-21 SELL -100 16.200 16.790 16.731 USD -1,673 0.00 Loss of -1,673 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	1,545	11.150	10.125	10.227	USD 15,801	9.39
2025-11-28	BUY	103	12.010	11.250	11.326	USD 1,167	9.38
2025-11-26	BUY	309	12.200	11.435	11.511	USD 3,557	9.35
2025-11-26	BUY	309	12.200	11.435	11.511	USD 3,557	9.35
2025-11-25	BUY	613	12.980	11.220	11.396	USD 6,986	9.34
2025-11-20	SELL	-412	9.290	8.530	8.606	USD -3,546	9.33 Profit of 296 on sale
2025-11-19	BUY	103	8.730	8.230	8.280	USD 853	9.33
2025-11-18	BUY	612	8.950	8.420	8.473	USD 5,185	9.33
2025-11-17	BUY	206	9.080	8.360	8.432	USD 1,737	9.34
2025-11-14	BUY	103	8.835	7.930	8.020	USD 826	9.34
2025-11-12	BUY	103	8.490	7.720	7.797	USD 803	9.35
2025-11-10	BUY	102	8.000	7.380	7.442	USD 759	9.37
2025-11-06	BUY	102	7.820	7.060	7.136	USD 728	9.39
2025-11-04	BUY	103	7.800	7.360	7.404	USD 763	9.42
2025-10-30	BUY	515	8.090	7.550	7.604	USD 3,916	9.44
2025-10-29	BUY	206	7.690	8.570	8.482	USD 1,747	9.45
2025-10-22	SELL	-408	8.120	8.650	8.597	USD -3,508	9.49 Profit of 365 on sale
2025-10-20	BUY	204	8.560	8.580	8.578	USD 1,750	9.50
2025-10-17	BUY	509	7.855	8.660	8.579	USD 4,367	9.51
2025-10-15	BUY	808	8.630	8.650	8.648	USD 6,988	9.52
2025-10-03	BUY	728	5.900	6.020	6.008	USD 4,374	9.55
2025-10-02	BUY	104	5.750	6.050	6.020	USD 626	9.57
2025-09-30	BUY	208	5.930	6.055	6.042	USD 1,257	9.62
2025-09-26	BUY	208	5.960	6.100	6.086	USD 1,266	9.66
2025-09-25	BUY	208	5.990	6.100	6.089	USD 1,267	9.68
2025-09-18	BUY	105	6.340	6.400	6.394	USD 671	9.70
2025-09-17	BUY	315	5.930	6.410	6.362	USD 2,004	9.73
2025-07-17	SELL	-204	7.770	7.960	7.941	USD -1,620	9.79 Profit of 378 on sale
2025-07-11	SELL	-824	7.700	7.830	7.817	USD -6,441	9.85 Profit of 1,673 on sale
2025-07-02	BUY	5,665	7.760	8.050	8.021	USD 45,439	9.90
2025-06-25	BUY	204	7.920	8.000	7.992	USD 1,630	9.96
2025-06-11	BUY	206	8.980	9.250	9.223	USD 1,900	10.09
2025-06-10	BUY	206	9.030	9.160	9.147	USD 1,884	10.10
2025-06-04	SELL	-103	9.070	9.360	9.331	USD -961	10.13 Profit of 83 on sale
2025-04-23	BUY	103	8.380	8.790	8.749	USD 901	10.79
2025-04-10	SELL	-816	7.580	7.610	7.607	USD -6,207	11.08 Profit of 2,836 on sale
2025-04-08	SELL	-102	7.320	7.830	7.779	USD -793	11.16 Profit of 345 on sale
2025-04-07	SELL	-102	7.250	7.390	7.376	USD -752	11.21 Profit of 391 on sale
2025-04-04	SELL	-515	7.410	7.615	7.594	USD -3,911	11.25 Profit of 1,885 on sale
2025-04-01	BUY	420	7.500	7.550	7.545	USD 3,169	11.34
2025-03-31	SELL	-312	7.570	7.900	7.867	USD -2,455	11.39 Profit of 1,098 on sale
2025-03-21	BUY	2,745	8.520	8.760	8.736	USD 23,980	11.63
2025-03-14	SELL	-1,520	8.790	9.010	8.988	USD -13,662	11.83 Profit of 4,317 on sale
2025-03-07	SELL	-190	8.710	9.090	9.052	USD -1,720	12.07 Profit of 572 on sale
2025-03-04	SELL	-95	8.130	8.315	8.296	USD -788	12.24 Profit of 375 on sale
2025-02-25	BUY	190	8.560	8.830	8.803	USD 1,673	12.57
2025-02-19	SELL	-94	9.430	9.470	9.466	USD -890	12.83 Profit of 316 on sale
2025-02-13	BUY	282	9.590	9.960	9.923	USD 2,798	13.10
2025-02-12	BUY	94	9.890	9.950	9.944	USD 935	13.16
2025-02-11	BUY	376	9.810	10.270	10.224	USD 3,844	13.23
2024-12-30	SELL	-2,885	12.200	12.280	12.272	USD -35,405	14.39 Profit of 6,096 on sale
2024-11-18	SELL	-1,500	13.450	14.145	14.076	USD -21,113	16.01 Profit of 2,905 on sale
2024-11-08	SELL	-100	16.020	16.450	16.407	USD -1,641	16.01 Loss of -40 on sale
2024-10-21	SELL	-100	16.200	16.790	16.731	USD -1,673	0.00 Loss of -1,673 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CGEM

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	91,713	0	453,137	20.2%
2025-09-18	29,909	64	374,322	8.0%
2025-09-17	29,113	561	152,081	19.1%
2025-09-16	41,765	2	156,366	26.7%
2025-09-15	69,037	556	213,450	32.3%
2025-09-12	76,084	0	383,502	19.8%
2025-09-11	66,615	867	581,520	11.5%
2025-09-10	55,097	0	308,725	17.8%
2025-09-09	106,491	0	278,733	38.2%
2025-09-08	44,979	0	172,182	26.1%
2025-09-05	92,584	2,960	314,975	29.4%
2025-09-04	218,977	13,252	745,971	29.4%
2025-09-03	59,535	0	162,544	36.6%
2025-09-02	30,215	0	107,256	28.2%
2025-08-29	28,955	0	102,690	28.2%
2025-08-28	39,008	0	89,895	43.4%
2025-08-27	50,544	0	153,481	32.9%
2025-08-26	38,684	3	378,657	10.2%
2025-08-25	17,620	0	58,531	30.1%
2025-08-22	73,100	0	173,435	42.1%
2025-08-21	27,559	0	85,312	32.3%
2025-08-20	37,739	0	91,418	41.3%
2025-08-19	37,960	0	83,526	45.4%
2025-08-18	77,212	0	180,135	42.9%
2025-08-15	37,996	0	114,067	33.3%
2025-08-14	15,179	0	186,706	8.1%
2025-08-13	25,903	0	130,511	19.8%
2025-08-12	44,973	0	119,053	37.8%
2025-08-11	41,962	128	103,183	40.7%
2025-08-08	67,304	2,573	153,714	43.8%
2025-08-07	80,102	176	173,936	46.1%
2025-08-06	21,373	0	51,516	41.5%
2025-08-05	22,741	0	58,650	38.8%
2025-08-04	26,114	0	93,276	28.0%
2025-08-01	38,240	579	76,874	49.7%
2025-07-31	35,027	58	68,864	50.9%
2025-07-30	80,500	0	739,899	10.9%
2025-07-29	58,393	9	130,459	44.8%
2025-07-28	27,557	0	46,548	59.2%
2025-07-25	21,736	176	36,209	60.0%
2025-07-24	54,730	18	130,095	42.1%
2025-07-23	77,967	0	133,955	58.2%
2025-07-22	49,802	0	89,671	55.5%
2025-07-21	27,480	0	40,112	68.5%
2025-07-18	29,606	0	50,251	58.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE